(Q33920258)

30 July 2017

title

Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix (English)

1 reference

30 July 2017

Sakiyama-Elbert SE

1

1 reference

30 July 2017

Hubbell JA

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Journal of Controlled Release

30 July 2017

published in

1 reference

30 July 2017

volume

69

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

149-158

1 reference

Pharmacological effects of nerve growth factor and fibroblast growth factor applied to the transectioned sciatic nerve on neuron death in adult rat dorsal root ganglia

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Nerve growth factor enhances regeneration through silicone chambers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Nerve growth factor in CNS repair

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Development of fibrin derivatives for controlled release of heparin-binding growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Dose-Dependent Effects of Recombinant Human NGF on Grafted Adult Adrenal Medullary Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Validation of a rat pheochromocytoma (PC12)-based cell survival assay for determining biological potency of recombinant human nerve growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Properties of receptors for nerve growth factor in the mature rat nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

The type 1 (EGFR-related) family of growth factor receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Role of transforming growth factor-beta in tissue injury and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900296-0

7 January 2021

10.1016/S0168-3659(00)00296-0

Identifiers

DOI

1 reference

30 July 2017

1 reference